Category Archives: Pr Newswire

Robust Profitable Growth amidst Consumption Mix-shiftAdjusted Net Income Grew 10.9% to RMB2.8 Billion US$0.35 per Share Interim Dividend Announced SHANGHAI, Aug. 21, 2024 /PRNewswire/ — ZTO Express (Cayman) Inc. (NYSE: ZTO and SEHK: 2057), a leading and fast-growing express delivery company in China (“ZTO” or the “Company”), today announced its unaudited financial results for the second […]

Robust Profitable Growth amidst Consumption Mix-shiftAdjusted Net Income Grew 10.9% to RMB2.8 Billion US$0.35 per Share Interim Dividend Announced SHANGHAI, Aug. 21, 2024 /PRNewswire/ — ZTO Express (Cayman) Inc. (NYSE: ZTO and SEHK: 2057), a leading and fast-growing express delivery company in China (“ZTO” or the “Company”), today announced its unaudited financial results for the second […]

TOKYO, Aug. 21, 2024 /PRNewswire/ — TOYO Co., Ltd (Nasdaq: TOYO) (“TOYO” or the “Company”), a solar solution company, today announced the Company will ring the closing bell at the Nasdaq MarketSite in Times Square, New York on Thursday August 22, 2024.  “We are excited and honored to ring the bell to commemorate our recent listing,” said Mr. Junsei Ryu, […]

RESEARCH TRIANGLE PARK, N.C., Aug. 20, 2024 (GLOBE NEWSWIRE) — Incyclix Bio, LLC, a next-generation cell cycle control company developing INX-315, a novel, potent and selective CDK2 inhibitor for the treatment of advanced and resistant cancer, today announced the appointment of Andrew Beelen, MD, as Vice President of Clinical Development. Dr. Beelen will be responsible […]

Continued progress in Phase 1/2a dose escalation for LAVA-1207, including the monotherapy arm, now enrolling in dose level 12, and the pembrolizumab combination Favorable safety profile for LAVA-1207 Next data update for LAVA-1207 program expected in Q4 2024 Strong balance sheet with cash of $86.8 million supports runway into mid-2026 UTRECHT, The Netherlands and PHILADELPHIA, […]

SCOTTSDALE, Ariz., Aug. 20, 2024 (GLOBE NEWSWIRE) — The Joint Corp. (NASDAQ: JYNT), the nation’s largest provider of chiropractic care through The Joint Chiropractic® network, announced that management plans to participate in the 7th Annual B. Riley Securities Consumer & TMT Conference on Thursday, September 12, 2024 at the Sofitel New York. President and CEO […]

caption: Sabin Vaccine Institute Research & Development President Kelly Warfield WASHINGTON, Aug. 20, 2024 (GLOBE NEWSWIRE) — Virologist and vaccine development leader Kelly Warfield has joined the Sabin Vaccine Institute as its Research & Development President to drive Sabin’s current candidate vaccines toward licensure and expand its pipeline. A member of Sabin’s executive team, Warfield […]

CATALYST is a Phase 2 single-blind, placebo-controlled, proof-of-concept study in patients presenting to the emergency department More than 27,569 individuals in the U.S. died from drug overdose deaths involving cocaine in 2022; there is currently no FDA-approved product for cocaine intoxication Topline results are expected in the first half of 2025 CHATHAM, N.J., Aug. 20, […]

Appointment adds biotech veteran with over two decades of business development, strategy, and operational experience to Cidara’s management team SAN DIEGO, Aug. 19, 2024 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of […]

Active engagement with the World Health Organization, U.S. government and other global health leaders on critical efforts to prevent mpox disease transmission 50,000 doses of ACAM2000®, (Smallpox (Vaccinia) Vaccine, Live) will be donated to Direct Relief for potential deployment across often difficult-to-reach locations, and as informed by local and regional health authorities GAITHERSBURG, Md., Aug. 19, […]